Related Experiment Video
Updated: May 19, 2026
06:51
Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
Published on: July 21, 2021
HSP60 as a drug target
Hiroyuki Nakamura1, Hidemitsu Minegishi
1Department of Chemistry, Faculty of Science, Gakushuin University, Japan. hiroyuki.nakamura@gakushuin.ac.jp
Current Pharmaceutical Design
|August 28, 2012
Summary
Heat shock protein 60 (HSP60) acts as a danger signal and potential biomarker in diseases. Targeting HSP60 shows promise for novel therapeutic strategies in various conditions, including cancer.
Area of Science:
- Molecular Biology
- Immunology
- Cellular Stress Response
Background:
- Heat shock proteins (HSPs) are conserved proteins induced by cellular stress.
- HSP60, a mitochondrial chaperone, assists protein folding and interacts with HSP10.
- HSP60 is found in various cellular compartments and extracellularly, acting as a danger signal.
Purpose of the Study:
- To review recent discoveries on HSP60's roles in diverse diseases.
- To summarize small molecules targeting HSP60.
- To examine HSP60 as a potential therapeutic target.
Main Methods:
- Literature review of recent discoveries on HSP60.
- Analysis of HSP60's role in diseases like autoimmune disorders and tumors.
- Summary of investigations into HSP60-targeting small molecules.
Main Results:
- HSP60 is implicated in proinflammatory responses and serves as a danger signal.
- Altered HSP60 levels correlate with carcinogenesis, suggesting biomarker potential.
- HSP60-targeting small molecules are under intensive investigation.
Conclusions:
- HSP60 plays significant roles in various diseases, including autoimmune conditions and cancers.
- HSP60's potential as a diagnostic and prognostic biomarker is highlighted.
- Targeting HSP60 represents a promising avenue for developing new therapeutic strategies.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...